CompletedPhase 4ACTRN12612000797875

Peak plasma propofol levels during endoscopy

Peak plasma propofol levels in endoscopy patients receiving a Propofol-only anaesthetic


Sponsor

Monash Medical Centre

Enrollment

10 participants

Start Date

Sep 8, 2011

Study Type

Interventional

Conditions

Summary

The peak plasma propofol levels of endoscopy patients (Derived mathematically from the 3 measurements) along with the context sensitive half time of propofol (determined by the length of infusion) will allow the researchers to determine the time taken for plasma propofol levels to drop below levels known to cause driving impairment and thus estimate how long it takes for patients to drive safely after receiving a propofol only anaesthetic.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Inclusion Criteria1

  • Undergoing colonoscopy or gastroscopy

Exclusion Criteria1

  • ASA 3 or 4

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Patients will receive propofol-only anaesthesia using the intermittent bolus technique. Propofol will be administered through an intravenous cannula using the intermittent bolus technique (large lo

Patients will receive propofol-only anaesthesia using the intermittent bolus technique. Propofol will be administered through an intravenous cannula using the intermittent bolus technique (large loading bolus followed by small frequent boluses) which titrates dosage to adequate sedation. The anaesthetist looking after the patient will give a propofol-only anaesthetic as per his or her usual procedure. The timing and dosage of boluses will not be stipulated by the researchers. The loading dose is given immediately prior to commencing the endoscopy. Further boluses are given when deemed required by the anaesthetist.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12612000797875